We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

234 hedge funds and large institutions have $3.41B invested in Jazz Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 234 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

57% less call options, than puts

Call options by funds: $26.3M | Put options by funds: $60.9M

Holders
234
Holders Change
+234
Holders Change %
–
% of All Funds
7.64%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
% of All Funds
0.33%
New
234
Increased
–
Reduced
–
Closed
–
Calls
$26.3M
Puts
$60.9M
Net Calls
-$34.6M
Net Calls Change
-$34.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SNC
201
Stifel Nicolaus & Co
Missouri
$226K +$201K +3,285 New
RG
202
Renaissance Group
Kentucky
$219K +$194K +3,180 New
DC
203
Deere & Company
Illinois
$219K +$195K +3,193 New
Marshall Wace
204
Marshall Wace
United Kingdom
$206K +$183K +3,000 New
ECM
205
ETrade Capital Management
Virginia
$203K +$180K +2,950 New
MCM
206
Munder Capital Management
Michigan
$156K +$139K +2,280 New
MTIP
207
Magee Thomson Investment Partners
California
$141K +$124K +2,036 New
Citigroup
208
Citigroup
New York
$136K +$120K +1,968 New
Group One Trading
209
Group One Trading
Illinois
$113K +$100K +1,642 New
US Bancorp
210
US Bancorp
Minnesota
$109K +$96.7K +1,582 New
Envestnet Asset Management
211
Envestnet Asset Management
Illinois
$105K +$93.3K +1,526 New
PCM
212
Prelude Capital Management
New York
$103K +$91.7K +1,500 New
RNS
213
Robert N. Shapiro
$103K +$91.7K +1,500 New
HTA
214
Haber Trilix Advisors
Massachusetts
$81K +$72.1K +1,180 New
New York State Common Retirement Fund
215
New York State Common Retirement Fund
New York
$76K +$67.2K +1,100 New
SSG
216
Summit Securities Group
New York
$67K +$59.3K +970 New
MFS
217
MSI Financial Services
Massachusetts
$64K +$57.1K +934 New
LTFS
218
Ladenburg Thalmann Financial Services
Florida
$62K +$55K +900 New
SAM
219
Solaris Asset Management
New York
$57K +$50.4K +825 New
FMT
220
First Mercantile Trust
Tennessee
$56K +$49.8K +815 New
BBHC
221
Brown Brothers Harriman & Co
New York
$41K +$36.7K +600 New
TRCT
222
Tower Research Capital (TRC)
New York
$31K +$27.1K +444 New
OA
223
OFI Advisors
Pennsylvania
$25K +$22.2K +363 New
ST
224
Smithfield Trust
Pennsylvania
$21K +$18.9K +310 New
BTS
225
BB&T Securities
Virginia
$20.4K +$1.81M +29,634 New
6 7 8
9
10

JAZZ Hedge Fund Activity: Q2 2013 in Review

234 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2013, worth a combined $3.41B.

Buyers outnumbered sellers: 234 funds opened new JAZZ positions and 0 closed out — a net gain of 234 holders — while 0 added to existing stakes and 0 trimmed.

  • 234 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.41B of Jazz Pharmaceuticals stock for Q2 2013.
  • 234 funds opened new Jazz Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +234 holders.

Based on aggregated 13F filings for Q2 2013.